5a13be122b
Co-Authored-By: Claude Opus 4.8 <noreply@anthropic.com>
89 lines
4.8 KiB
Markdown
89 lines
4.8 KiB
Markdown
---
|
||
type: "Bill"
|
||
title: "Medicaid participants; treatment involving the prescription of opioids, payment."
|
||
description: "Medicaid participants; treatment involving the prescription of opioids; payment. Prohibits licensed providers from requiring payment from Medicaid participants for the prescription of an opioid for the management of pain or the prescription of buprenorphine-containing products, methadone, or other opioid replacements approved for the treatment of opioid addiction by the U.S. Food and Drug Administration for medication-assisted treatment of opioid addiction, regardless of whether the provider participates in the state plan for medical assistance."
|
||
jurisdiction: "us/states/va"
|
||
legislature: "Virginia General Assembly"
|
||
session: "2022"
|
||
identifier: "SB 594"
|
||
citation: "Virginia SB 594 (2022)"
|
||
classification: ["bill"]
|
||
subjects: []
|
||
status: "enacted"
|
||
primary_sponsors: ["Todd E. Pillion"]
|
||
version_count: 3
|
||
action_count: 25
|
||
vote_count: 6
|
||
first_action: "2022-01-12"
|
||
last_action: "2022-04-08"
|
||
source: "openstates"
|
||
source_identifier: "ocd-bill/9727b688-3f38-4d36-b5e3-5352104917e7"
|
||
source_url: "https://lis.virginia.gov/cgi-bin/legp604.exe?221+sum+SB594"
|
||
source_hash: "6ed79162a501bdc046b43946b4676215d6ceaf543b618894fe0df3bb43957c93"
|
||
vintage: "2026-07-01"
|
||
source_snapshot: "https://data.openstates.org/daily/2026-07-01/public.pgdump"
|
||
retrieved_at: "2026-07-06"
|
||
confidence: "reported"
|
||
tags: ["legislation", "bill", "us-va"]
|
||
---
|
||
|
||
# Virginia SB 594 (2022) — Medicaid participants; treatment involving the prescription of opioids, payment.
|
||
|
||
Medicaid participants; treatment involving the prescription of opioids; payment. Prohibits licensed providers from requiring payment from Medicaid participants for the prescription of an opioid for the management of pain or the prescription of buprenorphine-containing products, methadone, or other opioid replacements approved for the treatment of opioid addiction by the U.S. Food and Drug Administration for medication-assisted treatment of opioid addiction, regardless of whether the provider participates in the state plan for medical assistance.
|
||
|
||
## Version chain
|
||
|
||
The bill's text revisions, in order — the diff chain from filing to enrollment.
|
||
|
||
1. **CHAP0214** (committee substitute) — [source](https://lis.virginia.gov/cgi-bin/legp604.exe?221+ful+CHAP0214)
|
||
2. **Prefiled and ordered printed; offered 01/12/22 22103669D** (committee substitute) — [source](https://lis.virginia.gov/cgi-bin/legp604.exe?221+ful+SB594)
|
||
3. **SB594ER** (committee substitute) — [source](https://lis.virginia.gov/cgi-bin/legp604.exe?221+ful+SB594ER)
|
||
|
||
## Votes
|
||
|
||
- Constitutional reading dispensed (40-Y 0-N) — **40–0** (pass) · upper
|
||
- Reported from Education and Health (15-Y 0-N) — **15–0** (pass) · upper
|
||
- VOTE: Passage (100-Y 0-N) — **99–0** (pass) · lower
|
||
- Constitutional reading dispensed (40-Y 0-N) — **40–0** (pass) · upper
|
||
- Passed Senate (40-Y 0-N) — **40–0** (pass) · upper
|
||
- Reported from Health, Welfare and Institutions (19-Y 2-N) — **19–2** (pass) · lower
|
||
|
||
## Sponsors
|
||
|
||
- Todd E. Pillion — primary (person)
|
||
|
||
## Timeline
|
||
|
||
The legislative action history — every referral, reading, and vote.
|
||
|
||
- **2022-01-12** Prefiled and ordered printed; offered 01/12/22 22103669D `introduction`
|
||
- **2022-01-12** Referred to Committee on Education and Health `referral-committee`
|
||
- **2022-01-21** Impact statement from DPB (SB594)
|
||
- **2022-01-31** Assigned Education sub: Health Professions `referral-committee`
|
||
- **2022-02-10** Reported from Education and Health (15-Y 0-N) `committee-passage`
|
||
- **2022-02-11** Constitutional reading dispensed (40-Y 0-N)
|
||
- **2022-02-14** Read second time and engrossed `reading-2`
|
||
- **2022-02-14** Constitutional reading dispensed (40-Y 0-N)
|
||
- **2022-02-14** Passed Senate (40-Y 0-N) `passage`
|
||
- **2022-02-22** Placed on Calendar
|
||
- **2022-02-22** Read first time `reading-1`
|
||
- **2022-02-22** Referred to Committee on Health, Welfare and Institutions `referral-committee`
|
||
- **2022-02-24** Reported from Health, Welfare and Institutions (19-Y 2-N) `committee-passage`
|
||
- **2022-02-28** Read second time `reading-2`
|
||
- **2022-03-01** Passed by for the day
|
||
- **2022-03-02** Read third time `reading-3`
|
||
- **2022-03-02** Passed House (100-Y 0-N) `passage`
|
||
- **2022-03-02** VOTE: Passage (100-Y 0-N)
|
||
- **2022-03-07** Enrolled
|
||
- **2022-03-08** Impact statement from DPB (SB594ER)
|
||
- **2022-03-08** Signed by President
|
||
- **2022-03-08** Signed by Speaker
|
||
- **2022-03-22** Enrolled Bill Communicated to Governor on March 22, 2022
|
||
- **2022-03-22** Governor's Action Deadline 11:59 p.m., April 11, 2022
|
||
- **2022-04-08** Approved by Governor-Chapter 214 (effective 7/1/22) `executive-signature`
|
||
|
||
## Source
|
||
|
||
OpenStates / OpenCivicData bulk snapshot [2026-07-01](https://data.openstates.org/daily/2026-07-01/public.pgdump); origin `ocd-bill/9727b688-3f38-4d36-b5e3-5352104917e7`. Confidence: reported (aggregated from official Virginia legislature records).
|
||
|